CLINICAL BENEFITS AND MECHANISMS OF A SUSTAINED RESPONSE TO INTERMITTENT INSULIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH SECONDARY DRUG FAILURE

被引：61
|
作者：
YKIJARVINEN, H
ESKO, N
EERO, H
MARJARIITTA, T
机构：
[1] UNIV HELSINKI,DEPT MED 2,SF-00100 HELSINKI 10,FINLAND
[2] UNIV HELSINKI,DEPT MED 3,SF-00100 HELSINKI 10,FINLAND
来源：
AMERICAN JOURNAL OF MEDICINE | 1988年 / 84卷 / 02期
关键词：
D O I：
10.1016/0002-9343(88)90412-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：185 / 192
页数：8
相关论文
共 50 条
  • [1] INTERMITTENT INTENSIVE INSULIN THERAPY AUGMENTS INSULIN-SECRETION AND ACTION IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH SECONDARY DRUG FAILURE
    TASKINEN, MR
    NIKKILA, EA
    HELVE, E
    YKIJARVINEN, H
    DIABETOLOGIA, 1986, 29 (08) : A599 - A599
  • [2] INSULIN VERSUS INSULIN PLUS SULFONYLUREAS IN TYPE-2 DIABETIC-PATIENTS WITH SECONDARY FAILURE TO SULFONYLUREAS
    SCHEEN, AJ
    LEFEBVRE, PJ
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1989, 6 (04) : S33 - S43
  • [3] SHORT-TERM INTENSIVE INSULIN THERAPY IMPROVES INSULIN SECRETORY CAPACITY AND INSULIN ACTION IN TYPE-2 DIABETIC-PATIENTS WITH SECONDARY DRUG FAILURE
    TASKINEN, MR
    NIKKILA, EA
    HELVE, E
    YKIJARVINEN, H
    DIABETES, 1986, 35 : A92 - A92
  • [4] EFFECT OF COMBINED INSULIN GLIPIZIDE THERAPY ON HDL-CHOLESTEROL IN SECONDARY FAILURE TYPE-2 DIABETIC-PATIENTS
    SIMPSON, HCR
    STIRLING, CA
    RECKLESS, JPD
    ATHEROSCLEROSIS, 1988, 74 (03) : 251 - 251
  • [5] A CLINICAL-TRIAL OF BAYM1099 IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH SECONDARY DRUG FAILURE
    LEIGH, P
    FONSECA, V
    WEERAKOON, J
    DANDONA, P
    DIABETOLOGIA, 1987, 30 (07) : A547 - A547
  • [6] START OF INSULIN-THERAPY IN TYPE-2 DIABETIC-PATIENTS
    BRUN, JM
    CATHELINEAU, G
    CHARBONNEL, B
    DROUIN, P
    DURLACH, V
    FONTAINE, P
    GUILLAUSSEAU, PJ
    HALIMI, S
    VEXIAU, P
    VIALETTES, B
    ZIEGLER, O
    DIABETES & METABOLISM, 1995, 21 (04): : 291 - 294
  • [7] CELLULAR AND HUMOURAL AUTOIMMUNITY MARKERS IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH SECONDARY DRUG FAILURE
    ZAVALA, AV
    DEBRUNO, LEF
    CARDOSO, AI
    MOTA, AH
    CAPUCCHIO, M
    POSKUS, E
    FAINBOIM, L
    BASABE, JC
    DIABETOLOGIA, 1992, 35 (12) : 1159 - 1164
  • [8] COMBINATION OF INSULIN WITH GLIPIZIDE INCREASES PERIPHERAL GLUCOSE DISPOSAL IN SECONDARY FAILURE TYPE-2 DIABETIC-PATIENTS
    SIMPSON, HCR
    STURLEY, R
    STIRLING, CA
    RECKLESS, JPD
    DIABETIC MEDICINE, 1990, 7 (02) : 143 - 147
  • [9] RESIDUAL EFFECTS OF A SHORT-TERM INTENSIFIED INSULIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH ORAL-DRUG FAILURE
    FERY, F
    DESIR, D
    MOCKEL, J
    DIABETES & METABOLISM, 1991, 17 (06): : 525 - 529
  • [10] THE MECHANISMS OF SECONDARY DRUG FAILURE IN PATIENTS WITH TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES
    GROOP, L
    PELKONEN, R
    KOSKIMIES, S
    DIABETOLOGIA, 1982, 23 (02) : 171 - 171
12345